We are live on ! Find out more
VKTXW

Viking Therapeutics, Inc.
VKTXW

Delisted

VKTXW was delisted on the 8th of April, 2021.

Back to rankings

2 hedge funds and large institutions have $422K invested in Viking Therapeutics, Inc. in 2020 Q3 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% less capital invested

Capital invested by funds: $632K → $422K (-$210K)

33% less funds holding

Funds holding: 3 → 2 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-1
Holders Change %
-33.33%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$62K
2
UBS Group
UBS Group
Switzerland
-$5.24K
Name Holding Trade Value Shares
Change 		Change in
Stake
PWAM
1
Park West Asset Management
California
$414K – – –
UBS Group
2
UBS Group
Switzerland
$8K -$5.24K -971 -34%
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
– -$62K -10,625 Closed

VKTXW Hedge Fund Activity: Q3 2020 in Review

2 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Viking Therapeutics, Inc. (VKTXW) for Q3 2020, worth a combined $422K — down 33% from $632K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of VKTXW and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.

The largest seller was Susquehanna International Group, exiting entirely with an estimated $62K sold.

  • 2 institutional investors held Viking Therapeutics, Inc. (VKTXW) as of Q3 2020, down from 3 in Q2 2020.
  • Funds reported $422K of Viking Therapeutics, Inc. stock for Q3 2020, down 33% quarter-over-quarter.
  • 0 funds opened new Viking Therapeutics, Inc. positions in Q3 2020 and 1 closed out, a net change of -1 holder.
  • The largest Viking Therapeutics, Inc. seller in Q3 2020 was Susquehanna International Group, an estimated $62K sold.

Based on aggregated 13F filings for Q3 2020.